Robert Oberlender
20Patents
15h-index
12Co-inventors
70Inventor score
Filing activity: Apr 10, 2006 → May 29, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7678770B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 55 | Active |
| US7671030B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 54 | Active |
| US7655630B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 45 | Active |
| US7659253B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 42 | Active |
| US7700561B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 40 | Active |
| US7674774B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7718619B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7687466B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7671031B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7723305B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7678771B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 39 | Active |
| US7659254B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 38 | Active |
| US7687467B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 25 | Active |
| US7713936B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US7662788B2 | Abuse-resistant amphetamine prodrugs | Emerging Cross-Sectional Technologies | 16 | Active |
| US8236787B2 | Frequency modulated drug delivery (FMDD) | Human Necessities | 3 | Active |
| US10150792B2 | Bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients | Chemistry; Metallurgy | 0 | Active |
| US8779175B2 | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients | Chemistry; Metallurgy | 0 | Active |
| US9624256B2 | Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients | Chemistry; Metallurgy | 0 | Active |
| US8716300B2 | Frequency modulated drug delivery (FMDD) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.